Geneos Wealth Management’s Proterra Inc. Common Stock PTRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,300
Closed -$2.76K 2158
2023
Q2
$2.76K Hold
2,300
﹤0.01% 1879
2023
Q1
$3.5K Hold
2,300
﹤0.01% 1809
2022
Q4
$8.67K Hold
2,300
﹤0.01% 1567
2022
Q3
$11K Sell
2,300
-2,000
-47% -$11.2K ﹤0.01% 1503
2022
Q2
$19K Buy
4,300
+2,800
+187% +$17.1K ﹤0.01% 1718
2022
Q1
$11K Buy
+1,500
New +$12.2K ﹤0.01% 2074

Other funds holding PTRA

Geneos Wealth Management's PTRA Position: Q3 2023 in Review

Geneos Wealth Management sold out of Proterra Inc. Common Stock (PTRA) in Q3 2023, closing a stake of 2,300 shares — an estimated $2.76K sold.

Geneos Wealth Management first reported a position in PTRA in Q1 2022 and held it in 6 quarters. The position peaked at $19K in Q2 2022. 7 funds tracked by Wall St. Rank hold PTRA as of Q3 2023.

  • Geneos Wealth Management reported no remaining Proterra Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Geneos Wealth Management sold 2,300 Proterra Inc. Common Stock shares in Q3 2023, an estimated $2.76K.
  • Geneos Wealth Management first reported a position in Proterra Inc. Common Stock in Q1 2022 and held it in 6 quarters.
  • Geneos Wealth Management's Proterra Inc. Common Stock position peaked at $19K in Q2 2022.
  • 7 funds tracked by Wall St. Rank held Proterra Inc. Common Stock as of Q3 2023.

Based on Geneos Wealth Management's 13F filing for Q3 2023, filed 11 Oct 2023.